Medical Data Vision (EBM Provider®) Health Insurance Association Database (Japan)

Database Contact Data

Medical Data Vision Co., Ltd.
Sumitomo Fudosan Kanda Bldg.
7 Kandamitoshirocho 
Chiyoda-ku
Tokyo 101-0053 
JAPAN
Phone: +81 3 5283 6911
Fax: +81 3 5283 6811
Email: ebm_sales@mdv.co.jp (English acceptable)

Alternate Contact

Please complete the contact form:https://en.mdv.co.jp/application/contactus/form.php

References of Studies Using/Describing Database

N/A

Jun 16, 2021: New database profile from the Netherlands

Managed by the Netherlands Comprehensive Cancer Organisation (IKNL), the Netherlands Cancer Registry is the only oncological hospital registry in the Netherlands with data on all cancer patients. Data are available on national level from 1989 onwards. The Netherlands has about 17,000,000 inhabitants. Annually, there are 116,500 new diagnoses of cancer and 44,000 cancer deaths in the Netherlands.

Netherlands Cancer Registry (Netherlands)

Database Contact Data

Jolanda Sinha
Press Officer
Postbus 19079, 3501 DB
Utrecht
THE NETHERLANDS
Email: j.sinha@iknl.nl
Phone: + 31 88 234 60 00
Mobile: +31 6 34 62 02 29

Alternate Contact

Dr. Otto Visser
Head of Cancer Registration
Postbus 19079, 3501 DB
Utrecht
THE NETHERLANDS
Email: o.visser@iknl.nl
Phone: + 31 88 234 60 00
Mobile: +31 6 18 41 86 67

References of Studies Using/Describing Database

1. Galanos LJK, Rijken A, Elferink MAG, Kok NFM, van Erning FN, De Hingh IHJT. Influence of a nationwide colorectal cancer screening program on the incidence of synchronous colorectal peritoneal metastases. Int J Cancer. 2025 Jul 15;157(2):232-238.

2. van Maaren MC, Voorham QJM, Wijnen EM, de Munck L, Wesseling J, Visser O, Siesling S. Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry. Cancer Epidemiol. 2025 Jun;96:102780. 

3. Kuijper SC, Gehrels AM, van der Geest LG, Verhoeven RHA, Koerkamp BG, Molenaar IQ, Stommel MWJ, de Meijer VE, de Vos-Geelen J, Wumkes ML, Besselink MG, Wilmink JW, van Laarhoven HWM; Dutch Pancreatic Cancer Group. Survival scenarios of patients with localized and metastatic pancreatic adenocarcinoma: A population-based study. Int J Cancer. 2025 May 1;156(9):1726-1735.

4. Darai A, Koëter T, van Erning FN, van Alphen RJ, Verheul HMW, Verheij M, Zimmerman DDE, Vissers PAJ, de Wilt JHW. The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands. Colorectal Dis. 2025 Mar;27(3):e70054.

5. Jutten E, van Kempen LCLT, Diercks GFH, van Leeuwen BL, Kruijff S, Wevers KP. Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma. Mol Diagn Ther. 2025 Mar;29(2):229-238.

6. Yildirim H, Richters A, Bins AD, Postema AW, Aarts MJB, van Oijen MGH, Zondervan PJ, Aben KKH. Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort. Eur Urol Open Sci. 2025 Feb 10;72:42-45.

7. van Doorn-Wink KCJ, Postmus PE, de Ruysscher D, Damhuis RAM. Ninety-day mortality following curative intent radiotherapy for stage I-III lung cancer in the Netherlands. Radiother Oncol. 2025 Feb;203:110661.

8. van Laarhoven H, Verhoeven R, van Berge Henegouwen M, Mohammad NH, van Hillegersberg R, Slingerland M, Muijs CT, Wijnhoven B, Mostert B, Beerepoot L, Nieuwenhuijzen G, Derks S, van Rossum PSN. Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands. EClinicalMedicine. 2025 Jan 22;80:103067.

9. Westerveld ASR, Tytgat GAM, van Santen HM, van Noesel MM, Loonen J, de Vries ACH, Louwerens M, Koopman MMW, van der Heiden-van der Loo M, Janssens GO, de Krijger RR, Ronckers CM, van der Pal HJH, Kremer LCM, Teepen JC. Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study. J Clin Oncol. 2025 Jan 10;43(2):154-166.

10. Mülder DT, van de Schootbrugge-Vandermeer HJ, O'Mahony JF, Sun D, Han W, Verhoeven RHA, van Loo M, van de Veerdonk W, Spaander MCW, Lansdorp-Vogelaar I. Gastric Cancer Risk among Immigrants and Socioeconomic Groups in the Netherlands. Cancer Epidemiol Biomarkers Prev. 2025 Jan 9;34(1):85-92.

Hospital Episode Statistics (HES) Database (United Kingdom)

Database Contact Data

Hospital Episode Statistics (HES)
NHS England Digital - https://digital.nhs.uk/services/hospital-episode-statistics

Alternate Contact

N/A

References of Studies Using/Describing Database

1. Valsamis EM, Sayers A, Ma J, Dhiman P, Gwilym SE, Rees JL. Evaluation of comorbidity measures for predicting mortality and revision surgery after elective primary shoulder replacement surgery based on data from the National Joint Registry and Hospital Episode Statistics for England: population based cohort study. BMJ Med. 2025 Aug 10;4(1):e001283.

2. Kong D, Linton S, Stapleton E. The incidence and epidemiology of necrotising otitis externa in England before, during and after the coronavirus disease 2019 pandemic: an updated analysis of Hospital Episode Statistics data 2002-2024. J Laryngol Otol. 2025 Jul 30:1-7.

3. Reid JP, Beech T, Muzaffar J. Return to theatre for post-tonsillectomy haemorrhage in children has not fallen with increased use of plasma ablation tonsillectomy: a retrospective analysis of 359,241 tonsillectomies in 15 years of United Kingdom Hospital Episode Statistics. PLoS One. 2025 Jul 28;20(7):e0328251.

4. Hall S, Gaastra B, Ewbank F, Birks J, Bulters D. Identifying elective treatment of unruptured intracranial aneurysms using the Hospital Episode Statistics database. Br J Neurosurg. 2025 Jul 2:1-6. doi: 10.1080/02688697.2025.2516025. Epub ahead of print.

5. O'Malley O, Davies A, Rangan A, Sabharwal S, Reilly P. Reverse shoulder arthroplasty for acute trauma vs. trauma sequalae following failed conservative management: a cohort study using data from the National Joint Registry and Hospital Episode Statistics for England. J Shoulder Elbow Surg. 2025 Jun 26:S1058-2746(25)00485-9. doi: 10.1016/j.jse.2025.05.016. Epub ahead of print.

6. Kruger E, Giblin S. Investigating the Secondary Care System Burden of Glycogen Storage Disease Type Ia (GSDIa) Using the Hospital Episode Statistics Database. J Health Econ Outcomes Res. 2025 May 28;12(1):201-206.

7. Matthews AH, Evans JP, Evans JT, Lamb S, Price AJ, Gray W, Briggs T, Toms AD. What is the impact of longer patient travel distances and times on perioperative outcomes following revision knee replacement: a retrospective observational study using data for England from Hospital Episode Statistics. BMJ Open. 2025 May 6;15(5):e085201.

8. Vella-Baldacchino M, Bottle A, Cobb J, Liddle AD. Outcomes of patellofemoral joint arthroplasty compared with total knee arthroplasty for osteoarthritis : a population-based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England. Bone Joint J. 2025 May 1;107-B(5):514-521.

9. Heining C, Clark M. Surgical arrest of post-tonsillectomy haemorrhage: hospital episode statistics 2016-2022. Ann R Coll Surg Engl. 2025 Mar;107(3):206-210.

10. Jangan A, Watts E, Pankhania M. Coin-cidence? Have cashless payments reduced the incidence of upper aerodigestive foreign body insertion? A study of UK Hospital Episode Statistics. Ann R Coll Surg Engl. 2025 Feb;107(2):125-129.

Subscribe to